The perceived importance of K2P channel current-density in a number of diseases states including cancer, neuropathic pain and depression [4, 5, 43, 61] suggests that a better understanding of the mechanisms and regulations that underpin the trafficking of these channels to the plasma membrane and to localised regions therein, may considerably enhance the probability of future therapeutic advances in these areas. The gene discussed is KRT76; the disease is cancer.